HTG MOLECULAR DIAGNOSTICS, INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Htg Molecular Diagnostics, Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2022.
  • Htg Molecular Diagnostics, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $59.8M, a 10.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $59.8M +$5.85M +10.8% Dec 31, 2022 10-K 2023-03-30
Q4 2021 $54M +$5.33M +11% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $48.6M +$5.28M +12.2% Dec 31, 2020 10-K 2022-03-29
Q4 2019 $43.4M +$4.61M +11.9% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $38.7M +$3.73M +10.7% Dec 31, 2018 10-K 2020-03-25
Q4 2017 $35M -$8.47M -19.5% Dec 31, 2017 10-K 2019-03-07
Q4 2016 $43.5M +$9.54M +28.1% Dec 31, 2016 10-K 2018-03-23
Q4 2015 $33.9M +$8.74M +34.7% Dec 31, 2015 10-K 2017-03-23
Q4 2014 $25.2M Dec 31, 2014 10-K 2016-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.